Presented at the Addiction Health Services Research Conference, Lexington, Kentucky, October 25-27, 2010
James L. Sorensen, PhD (San Francisco General Hospital, UCSF, WS Node), P. Todd Korthius, MD, MPH (Oregon Health & Science University, WS Node), Louise F. Haynes, MSW (Lexington/Richland Alcohol and Drug Abuse Council, SC Node), Daniel J. Feaster, PhD (University of Miami Miller School of Medicine, FNA Node), Susan Tross, PhD (New York State Psychiatric Hospital, GNY Node), Raul N. Mandler, MD (Center for the Clinical Trials Network, NIDA), Lauren K. Gooden, MPH (University of Miami Miller School of Medicine, FNA Node), Tim Matheson, PhD (San Francisco Department of Public Health, WS Node), Lisa R. Metsch, PhD (University of Miami Miller School of Medicine, FNA Node).
HIV testing is changing, as new technology allows testing with results in 20 minutes and studies show much transmission is by people unaware they have HIV. The CDC now recommends more testing and less counseling at the time of testing. This presentation served as an introduction to a session at the conference focused on a multicenter study being conducted in the National Drug Abuse Treatment Clinical Trials Network (CTN), protocol CTN-0032. The aim of 0032 is to evaluate a more effective HIV testing strategy designed to increase receipt of HIV test results and decrease HIV sexual risk behaviors. Study participants were 1281 drug treatment clients enrolled at 12 community treatment programs who reported not being HIV positive and not recently receiving test results. Sites launched in early 2009 and outcomes are pending. This session will address participants' baseline HIV and HCV status and testing history, levels of hepatitis C awareness and risky injection behaviors, and how one community treatment program integrated HIV testing into routine clinic services. (Presentation, PowerPoint slides, English, 2010)
Keywords: Adoption of interventions | Community health services | Hepatitis C | HIV/AIDS | HIV rapid testing | Sexual risk behavior | Sexually transmitted diseases | Addiction Health Services Research Conference, 2010
Document No: 543
Submitted by James Sorensen, PhD, San Francisco General Hospital, UCSF, WS Node, 11/10/2010.